Frontcourt Ventures

Frontcourt Ventures is the venture investment arm of Frontcourt Group, an investment bank and consulting firm founded in 2013 by Robert Sawicki and headquartered in Basking Ridge, New Jersey. Frontcourt Group's primary business is mergers and acquisitions advisory, capital raising, business valuations, financial modeling, strategic planning, and recapitalization services for emerging-growth and middle-market companies. The venture arm channels capital sourced from exclusive investment vehicles backed by large family offices, prominent industry executives, and high-net-worth individuals into equity positions within healthcare and technology companies. Frontcourt Capital, the venture vehicle, targets healthcare-focused companies including medical technology, pharmaceuticals, and healthcare services, investing at Series A and Series B stages. The venture activity is opportunistic rather than programmatic, with investments identified through the firm's advisory relationships rather than from a dedicated fund with a fixed deployment schedule. The only publicly documented portfolio investment is Aria CV, a medical device company focused on pulmonary arterial hypertension, backed as part of a Series B round in January 2020. Frontcourt's model integrates investment activity with advisory services: portfolio companies receive not only equity capital but also the firm's corporate finance expertise, governance support, and access to the executive and family office networks that back Frontcourt Capital. This alignment of advisory and investment interests gives Frontcourt a differentiated role in the healthcare and technology middle market, though the venture activity has been limited in volume relative to the broader advisory business.